Wide host range and strong lytic activity of staphylococcus aureus lytic phage Stau2

Applied and Environmental Microbiology

Volumn 77, Issue 3, 2011, Pages 756-761

  Hsieh, Sue Er ^a   Lo, Hsueh Hsia ^a   Chen, Shui Tu ^b   Lee, Mong Chuan ^a   Tseng, Yi Hsiung ^c  

^a CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b Nantou Hospital   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBACTERIAL AGENT; BURST SIZE; DOUBLE STRANDED DNA; FOOD INDUSTRIES; LIQUID CULTURE; MULTIPLICITY OF INFECTIONS; PHAGE THERAPY; RESISTANT STAPHYLOCOCCUS AUREUS; ROOM TEMPERATURE; S. AUREUS; STAPHYLOCOCCUS AUREUS;

CELL CULTURE;

ENZYME INHIBITION;

ANTIINFECTIVE AGENT;

ANTIMICROBIAL ACTIVITY; BACTERIUM; BIOCHEMICAL COMPOSITION; FOOD INDUSTRY; GENOME; HOST RANGE; MORPHOLOGY; PH; RODENT; SALINITY;

ANIMAL; ARTICLE; BACTERIOLYSIS; BACTERIOPHAGE; BAGG ALBINO MOUSE; CLASSIFICATION; DRUG EFFECT; GENETICS; GROWTH, DEVELOPMENT AND AGING; HOST RANGE; HUMAN; LYSOGENIZATION; MALE; MICROBIOLOGY; MOUSE; PATHOGENICITY; PHYSIOLOGY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STAPHYLOCOCCUS PHAGE; TREATMENT OUTCOME; ULTRASTRUCTURE; VIROLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIOLYSIS; HOST SPECIFICITY; HUMANS; LYSOGENY; MALE; MICE; MICE, INBRED BALB C; MYOVIRIDAE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PHAGES; TREATMENT OUTCOME;

MUS; MYOVIRIDAE; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 79551495634     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.01848-10     Document Type: Article

References (28)

1. Ackermann, H. W. 2001. Frequency of morphological phage descriptions in the year 2000. Brief review. Arch. Virol. 146:843-857.
2. Alisky, J., K. Iczkowski, A. Rapoport, and N. Troitsky. 1998. Bacteriophages show promise as antimicrobial agents. J. Infect. 36:5-15.
3. Appelbaum, P. C. 2006. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 12(Suppl. 1):16-23.
4. Bren, L. 2007. Bacteria-eating virus approved as food additive. FDA Con-sum. 41:20-22.
5. Brüssow, H. 2005. Phage therapy: the Escherichia coli experience. Microbiology 151:2133-2140.
6. Hagens, S., and M. J. Loessner. 2007. Application of bacteriophages for detection and control of foodborne pathogens. Appl. Microbiol. Biotechnol. 76:513-519.
7. Hsueh, P. R., C. Y. Liu, and K. T. Luh. 2002. Current status of antimicrobial resistance in Taiwan. Emerg. Infect. Dis. 8:132-137.
8. Hsueh, P. R., et al. 2004. Increasing prevalence of methicillin-resistant Staph-ylococcus aureus causing nosocomial infections at a university hospital in Taiwan from 1986 to 2001. Antimicrob. Agents Chemother. 48:1361-1364.
9. Kutter, E. 2009. Phage therapy: bacteriophages as natural, self-replicating antimicrobials, p. 713-730. In E. Goldman and L. H. Green (ed.), Practical handbook of microbiology, 2nd ed. CRC Press, Boca Raton, FL.
10. Kwan, T., J. Liu, M. DuBow, P. Gros, and J. Pelletier. 2005. The complete genomes and proteomes of 27 Staphylococcus aureus bacteriophages. Proc. Natl. Acad. Sci. U. S. A. 102:5174-5179.
11. Matsuzaki, S., et al. 2005. Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases. J. Infect. Chemother. 11:211-219.
12. Matsuzaki, S., et al. 2003. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. J. Infect. Dis. 187:613-624.
13. O'Flaherty, S., et al. 2005. Isolation and characterization of two anti-staph-ylococcal bacteriophages specific for pathogenic Staphylococcus aureus associated with bovine infections. Lett. Appl. Microbiol. 41:482-486.
14. O'Flaherty, S., et al. 2005. Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals. Appl. Environ. Microbiol. 71:1836-1842.
15. Pajunen, M., S. Kiljunen, and M. Skurnik. 2000. Bacteriophage 4>YeO3-12, specific for Yersinia enterocolitica serotype O:3, is related to coliphages T3 and T7. J. Bacteriol. 182:5114-5120.
16. Palazzo, I. C, M. L. Araujo, and A. L. Darini. 2005. First report ofvanco-mycin-resistant staphylococci isolated from healthy carriers in Brazil. J. Clin. Microbiol. 43:179-185.
17. Pantucek, R., et al. 1998. The polyvalent staphylococcal phage phi 812: its host-range mutants and related phages. Virology 246:241-252.
18. Pirisi, A. 2000. Phage therapy-advantages over antibiotics? Lancet 356: 1418.
19. Rees, P. J., and B. A. Fry. 1981. The morphology of staphylococcal bacteriophage K and DNA metabolism in infected Staphylococcus aureus. J. Gen. Virol. 53:293-307.
20. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed., vol. 1. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
21. Sulakvelidze, A., Z. Alavidze, and J. G. Morris, Jr. 2001. Bacteriophage therapy. Antimicrob. Agents Chemother. 45:649-659.
22. Summers, W. C. 2001. Bacteriophage therapy. Annu. Rev. Microbiol. 55: 437-451.
23. Synnott, A. J., et al. 2009. Isolation from sewage influent and characterization of novel Staphylococcus aureus bacteriophages with wide host ranges and potent lytic capabilities. Appl. Environ. Microbiol. 75:4483-4490.
24. Tiwari, H. K., and M. R. Sen. 2006. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infect. Dis. 6:156.
25. Uchiyama, J., et al. 2008. Isolation and characterization of a novel Entero-coccus faecalis bacteriophage phiEF24C as a therapeutic candidate. FEMS Microbiol. Lett. 278:200-206.
26. Wang, J. L., S. P. Tseng, P. R. Hsueh, and K. Hiramatsu. 2004. Vancomycin heteroresistance in methicillin-resistant Staphylococcus aureus, Taiwan. Emerg. Infect. Dis. 10:1702-1704. (Pubitemid 39201539)
27. Watanabe, R., et al. 2007. Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice. Antimicrob. Agents Chemother. 51:446-452.
28. Weigel, L. M., et al. 2003. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302:1569-1571.